Results 211 to 220 of about 30,963 (261)
Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain. [PDF]
Ophthalmol TherRuiz-Moreno JM +7 more
europepmc +1 more source
What have we learned from a decade treating patients with diabetic macular oedema with 0.19 mg fluocinolone acetonide intravitreal implant? [PDF]
Eye (Lond)Kodjikian L +4 more
europepmc +1 more source
Use of a multifocal electroretinogram to evaluate the therapeutic effect of a single intravitreal dexamethasone implant, Ozurdex<sup>®</sup>, for refractory diabetic macular oedema. [PDF]
Int J Retina VitreousMohammed ARA +3 more
europepmc +1 more source
Intravitreal steroids in the management of macular oedema [PDF]
Acta Ophthalmologica, 2006 Abstract.The use of intravitreal corticosteroids in the management of macular oedema has recently gained widespread acceptance. New long‐acting steroid preparations and methods of delivery have facilitated the use of these new modalities. This review describes the various types of macular oedema for which this therapeutic option is used and the results.
Sobha Sivaprasad +2 more
exaly +3 more sources
Serous macular detachment in diabetic cystoid macular oedema [PDF]
Acta Ophthalmologica, 2005 Abstract.Purpose: To define serous macular detachment in patients with diabetic cystoid macular oedema (CME). Methods: This study involved 78 eyes of 58 patients with diabetic CME. The patients underwent complete ophthalmic examination, fluorescein angiography and optical coherence tomography (OCT).
Murat Karaçorlu
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet Diabetes & Endocrinology, 2017
Diabetic macular oedema, characterised by exudative fluid accumulation in the macula, is the most common form of sight-threatening retinopathy in people with diabetes. It affects one in 15 people with diabetes resulting in more than 20 million cases worldwide.
Gavin S, Tan +4 more
openaire +2 more sources
Diabetic macular oedema, characterised by exudative fluid accumulation in the macula, is the most common form of sight-threatening retinopathy in people with diabetes. It affects one in 15 people with diabetes resulting in more than 20 million cases worldwide.
Gavin S, Tan +4 more
openaire +2 more sources
Unilateral macular oedema in Zermatt and Stargardt macular dystrophies
British Journal of Ophthalmology, 2008Zermatt macular dystrophy is a dominantly inherited pattern dystrophy caused by the R172W mutation of the RDS/peripherin gene and named after the Zermatt area of Switzerland.1 It shows small and round macular drusen early in life which are characterised by a very bright and early hyperfluorescent pattern suggestive of basal laminar drusen.1 ...
H, Abouzeid +3 more
openaire +2 more sources